Browse by author
Lookup NU author(s): Dr Mary Slatter,
Dr Baidik Bhattacharya,
Dr Terence Flood,
Dr Mario Abinun,
Professor Andrew Cant,
Professor Andrew GenneryORCiD
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Wiskott-Aldrich syndrome, an X-linked primary immunodeficiency can be cured by bone marrow transplantation. Umbilical cord haemopoietic stem cells are increasingly used as an alternative to bone marrow; advantages include ready availability, no risk to the donor, low rate of viral contamination, and low risk of graft versus host disease. Disadvantages include low stem cell dose for larger patients and lack of stem cells for boost infusions following the initial procedure. We report the case of a child with Wiskott-Aldrich syndrome who underwent cord blood stem cell transplantation with two separate cord blood units, 8 days apart. © 2005 Wiley-Liss, Inc.
Author(s): Slatter MA, Bhattacharya A, Flood TJ, Abinun M, Cant AJ, Gennery AR
Publication type: Article
Publication status: Published
Journal: Pediatric Blood and Cancer
ISSN (print): 1545-5009
ISSN (electronic): 1545-5017
Publisher: John Wiley & Sons, Inc.
Altmetrics provided by Altmetric